Agios Pharma (AGIO) Tops Q2 EPS by 5c

Agios Pharma (NASDAQ: AGIO) reported Q2 EPS of ($1.51), $0.05 better than the analyst estimate of ($1.56). Revenue for the quarter came in at $6.7 million versus the consensus estimate of $6.54 million.

For earnings history and earnings-related data on Agios Pharma (AGIO) click here.

You May Also Be Interested In

• Jefferies upgrades Shopify to Buy on AI commerce tailwinds, sees 30% upside
• Sanuwave Q2 2026 revenue tops revised guidance range
• J.B. Hunt Transport Services (JBHT) PT Raised to $261 at Stifel Into Q2 Earnings